InMed Pharmaceuticals (INM) Stock Price
InMed Pharmaceuticals Price
Over the last 19 years InMed Pharmaceuticals grew revenue by 3.4% annually, reaching 4.94 M USD. For InMed Pharmaceuticals, the net margin of -165.1% is up versus -775.0% a few years ago.
InMed Pharmaceuticals stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
InMed Pharmaceuticals business model & stock analysis
Frequently asked questions about InMed Pharmaceuticals
8 analysts currently rate the InMed Pharmaceuticals stock: 0 recommend buying, 3 holding and 5 selling.
Converted at the current exchange rate, the InMed Pharmaceuticals share trades at 1.50 EUR (1.68 USD).
The InMed Pharmaceuticals share (INM) is listed on 3 stock exchanges, including: NASDAQ (INM), Frankfurt (MWG0.F), München (MWG0.MU).
The revenue cannot currently be calculated for InMed Pharmaceuticals.
The profit cannot currently be calculated for InMed Pharmaceuticals.
The P/E ratio cannot be calculated for InMed Pharmaceuticals at the moment.
The P/S cannot be calculated for InMed Pharmaceuticals currently.
The Eulerpool Quality Score for InMed Pharmaceuticals is 4/10.
The ISIN of InMed Pharmaceuticals is CA4576377002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of InMed Pharmaceuticals is A3DTK2. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of InMed Pharmaceuticals is INM. The ticker symbol is used to trade InMed Pharmaceuticals shares on the stock exchange.
InMed Pharmaceuticals stock
InMed Pharmaceuticals Peer Group
InMed Pharmaceuticals Ticker
All fundamentals and in-depth analysis of InMed Pharmaceuticals
Our stock analysis for InMed Pharmaceuticals stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of InMed Pharmaceuticals. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.